Serum Institute gets nod to resume vaccine trial in India

Drugs Controller General of India Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while......

DCGI orders Serum to suspend recruitment for COVID-19 vaccine trials

Drugs Controller General of India has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate in......

India will wait for DCGI nod to restart Oxford vaccine trial

The global trials were halted after a study participant suffered a ‘potentially unexplained illness', reports Sohini Das. IMAGE: Serum Institute of India is the Indian partner of AstraZeneca......